Jamal A. Ibdah

9.5k total citations · 1 hit paper
153 papers, 7.1k citations indexed

About

Jamal A. Ibdah is a scholar working on Epidemiology, Molecular Biology and Physiology. According to data from OpenAlex, Jamal A. Ibdah has authored 153 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Epidemiology, 45 papers in Molecular Biology and 38 papers in Physiology. Recurrent topics in Jamal A. Ibdah's work include Liver Disease Diagnosis and Treatment (71 papers), Adipose Tissue and Metabolism (26 papers) and Diet, Metabolism, and Disease (24 papers). Jamal A. Ibdah is often cited by papers focused on Liver Disease Diagnosis and Treatment (71 papers), Adipose Tissue and Metabolism (26 papers) and Diet, Metabolism, and Disease (24 papers). Jamal A. Ibdah collaborates with scholars based in United States, United Kingdom and Zambia. Jamal A. Ibdah's co-authors include R. Scott Rector, John P. Thyfault, Fatiha Nassir, Yongzhong Wei, Frank W. Booth, E. Matthew Morris, Michael C. Phillips, Sarah J. Borengasser, Matthew J. Laye and M. Harold Laughlin and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Jamal A. Ibdah

148 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD

2022 147 citations Mary P. Moore, Rory P. Cunningham et al. profile →

Peers

Countries citing papers authored by Jamal A. Ibdah

Since Specialization

Citations

This map shows the geographic impact of Jamal A. Ibdah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamal A. Ibdah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamal A. Ibdah more than expected).

Fields of papers citing papers by Jamal A. Ibdah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jamal A. Ibdah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamal A. Ibdah. The network helps show where Jamal A. Ibdah may publish in the future.

Co-authorship network of co-authors of Jamal A. Ibdah

This figure shows the co-authorship network connecting the top 25 collaborators of Jamal A. Ibdah. A scholar is included among the top collaborators of Jamal A. Ibdah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamal A. Ibdah. Jamal A. Ibdah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Histological improvements following energy restriction and exercise: The role of insulin resistance in resolution of MASH 2024 ·Journal of Hepatology ·(unknown), Amadeo F. Salvador, Mary P. Moore, (unknown), Jennifer M. Anderson, (unknown), Rory P. Cunningham, Guido Lastra, Ayman H. Gaballah, Alberto A. Diaz‐Arias, Jamal A. Ibdah, R. Scott Rector, Elizabeth J. Parks	20
2	Relationship between serum β-hydroxybutyrate and hepatic fatty acid oxidation in individuals with obesity and NAFLD 2024 ·American Journal of Physiology-Endocrinology and Metabolism ·Mary P. Moore, (unknown), (unknown), (unknown), Grace M. Meers, Sarah A. Johnson, Andrew A. Wheeler, Jamal A. Ibdah, Elizabeth J. Parks, R. Scott Rector	12
3	Hepatocellular RECK as a Critical Regulator of Metabolic Dysfunction-associated Steatohepatitis Development 2024 ·Cellular and Molecular Gastroenterology and Hepatology ·(unknown), Rory P. Cunningham, Christopher L. Taylor, (unknown), (unknown), Grace M. Meers, Andrew A. Wheeler, Jamal A. Ibdah, Elizabeth J. Parks, Tadashi Yoshida, Bysani Chandrasekar, R. Scott Rector	4
4	Labeled breath tests in patients with NASH: Octanoate oxidation relates best to measures of glucose metabolism 2023 ·Frontiers in Physiology ·(unknown), (unknown), (unknown), Alberto A. Diaz‐Arias, Jamal A. Ibdah, R. Scott Rector, Elizabeth J. Parks	1
5	Thyroid Hormone and Mitochondrial Dysfunction: Therapeutic Implications for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 2023 ·Cells ·Raghu Ramanathan, (unknown), Ahmad H. Ali, Jamal A. Ibdah	16
6	The Utility and Diagnostic Accuracy of Transient Elastography in Adults with Morbid Obesity: A Prospective Study 2022 ·Journal of Clinical Medicine ·Ahmad H. Ali, (unknown), Gregory F. Petroski, Alberto A. Diaz‐Arias, Majid Mufaqam Syed‐Abdul, Andrew A. Wheeler, Rama Ganga, (unknown), Nicole Spencer, Ghassan M. Hammoud, R. Scott Rector, Elizabeth J. Parks, Jamal A. Ibdah	20
7	Improvements in nonalcoholic fatty liver disease (NAFLD) after metabolic surgery is linked to an increased hepatic fatty acid oxidation—a case report 2021 ·PubMed ·Majid Mufaqam Syed‐Abdul, Mary P. Moore, Andrew A. Wheeler, Rama Ganga, Alberto A. Diaz‐Arias, R. Scott Rector, Jamal A. Ibdah, Elizabeth J. Parks	3
8	eNOS deletion impairs mitochondrial quality control and exacerbates Western diet-induced NASH 2019 ·American Journal of Physiology-Endocrinology and Metabolism ·Ryan D. Sheldon, Grace M. Meers, E. Matthew Morris, Melissa A. Linden, Rory P. Cunningham, Jamal A. Ibdah, John P. Thyfault, M. Harold Laughlin, R. Scott Rector	38
9	Treating NAFLD in OLETF Rats with Vigorous-Intensity Interval Exercise Training 2014 ·Medicine & Science in Sports & Exercise ·Melissa A. Linden, Justin A. Fletcher, E. Matthew Morris, Grace M. Meers, M. Harold Laughlin, Frank W. Booth, James R. Sowers, Jamal A. Ibdah, John P. Thyfault, R. Scott Rector	72
10	Oxidative Stress-Mediated Mitochondrial Dysfunction Contributes to Angiotensin II-Induced Nonalcoholic Fatty Liver Disease in Transgenic Ren2 Rats 2009 ·American Journal Of Pathology ·Yongzhong Wei, Suzanne E. Clark, John P. Thyfault, Grace M.E. Uptergrove, Wenhan Li, Adam Whaley‐Connell, Carlos M. Ferrario, James R. Sowers, Jamal A. Ibdah	57
11	Low Aerobic Capacity and High-Fat Diet Contribute to Oxidative Stress and IRS-1 Degradation in the Kidney 2009 ·American Journal of Nephrology ·E. Matthew Morris, Adam Whaley‐Connell, John P. Thyfault, Steven L. Britton, Lauren G. Koch, Yongzhong Wei, Jamal A. Ibdah, James R. Sowers	18
12	Role of the JNK signal transduction pathway in inflammatory bowel disease 2008 ·World Journal of Gastroenterology ·Praveen K. Roy, Farzana Rashid, (unknown), Jamal A. Ibdah, (unknown), (unknown), (unknown), (unknown)	123
13	Mitochondrial trifunctional protein defects: Clinical implications and therapeutic approaches 2008 ·Advanced Drug Delivery Reviews ·R. Scott Rector, R. Mark Payne, Jamal A. Ibdah	44
14	En bloc endoscopic submucosal dissection of a 14-cm laterally spreading adenoma of the rectum with involvement to the anal canal: expanding the frontiers of endoscopic surgery (with video) 2008 ·Gastrointestinal Endoscopy ·Mainor R. Antillon, (unknown), Marc L. Miller, Alberto A. Diaz‐Arias, Jamal A. Ibdah, John B. Marshall	50
15	How good is endoscopic ultrasound for TNM staging of gastric cancers? A meta-analysis and systematic review 2008 ·World Journal of Gastroenterology ·Srinivas R. Puli, Jyotsna Batapati Krishna Reddy, Matthew L. Bechtold, Mainor R. Antillon, Jamal A. Ibdah	85
16	Nonalcoholic Steatohepatitis and the Cardiometabolic Syndrome 2006 ·PubMed ·(unknown), (unknown), Melvin R. Hayden, Jamal A. Ibdah	21
17	Impaired fatty acid oxidation as a cause of liver disease associated with hyperemesis gravidarum 2005 ·Medical Hypotheses ·(unknown), Jamal A. Ibdah	19
18	Intestinal pseudo-obstruction as a manifestation of impaired mitochondrial fatty acid oxidation 2004 ·Medical Hypotheses ·Jeffrey Gilbert, Jamal A. Ibdah	6
19	Inherited long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and a fetal-maternal interaction cause maternal liver disease and other pregnancy complications 1999 ·Seminars in Perinatology ·Arnold W. Strauss, Malcolm J. Bennett, Piero Rinaldo, Harold F. Sims, (unknown), Yiwen Zhao, Beverly Gibson, Jamal A. Ibdah	60
20	A comparison of the surface activities of human apolipoproteins A-I and A-II at the air/water interface 1988 ·Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·Keith E. Krebs, Jamal A. Ibdah, Michael C. Phillips	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact